Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High concentrated sodium citrate versus ACD-A for leukapheresis without heparin
jRCTs061250017Recruiting
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of trisodium citrate in None (2 arms). Primary endpoint: procedure time due to apheresis. Started May 2025; status: recruiting.
02
Drugs
trisodium citrate
Beyond the preview
Go deeper on jRCTs061250017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs061250017.